Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Midsummer AB is a Sweden-based company that specializes in the development and production of advanced thin-film solar cells and panels. The company is known for its proprietary DUO system, which is used to manufacture their lightweight, flexible, and environmentally-friendly solar solutions. Midsummer AB's technologies primarily serve the renewable energy sector, providing efficient solar panel alternatives that can be integrated into buildings and other structures where traditional solar panels may not be suitable. The company's focus on sustainability and innovation is evident in its approach to creating energy solutions that align with ecological best practices. Midsummer AB plays a crucial role in advancing solar technology, contributing to the global shift towards cleaner energy sources and supporting various industries in their efforts to reduce carbon footprints.
kr 0.10
+kr 0.01 (+5.50%)
Live · 10:45 PM · Twelve Data
The business is unprofitable at the operating level (-38.24% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 215.5% YoY with margins expanding 203.9pp.
Negative free cash flow of -kr 79M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
kr 214M
▲ +215.5% YoY
Net Income (TTM)
-kr 36M
▲ +42.5% YoY
Op. Margin
-3.09%
▲ +203.9pp YoY
ROIC
-14.81%
▲ +11.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
kr 7M
▼ -10.8% YoY
Op. Cash Flow (TTM)
kr 57M
▼ -13.5% YoY
Net Debt
kr 206M
Cash & Equiv.
kr 29M
3Y CAGR: +45.5%
Continue Research
Midsummer AB (MIDS.XSTO) trades above a two-stage DCF intrinsic value of about SEK -0.09 per share, so at SEK 0.10 the stock looks overvalued (192.6% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Midsummer AB scores 54/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about SEK -0.09 per share for MIDS.XSTO, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around SEK -0.07. At today's SEK 0.10, that puts the stock about 192.6% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Midsummer AB scores 54 out of 100 on Intrinsiqq's quality score, passing 3 of 6 checks, which makes it a mixed business on these measures. Recent fundamentals include a -3.1% operating margin and a -14.8% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full check-by-check breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. MIDS.XSTO currently trades above its estimated intrinsic value and scores 54/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.